Krishnan Suma
President, R&D · 63 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-04 | KRYS | Krystal Biotech, Inc. | Sale | 12,729 | $307.81 | $3.9M | filing |
| 2026-06-04 | KRYS | Krystal Biotech, Inc. | Sale | 3,803 | $308.89 | $1.2M | filing |
| 2026-06-04 | KRYS | Krystal Biotech, Inc. | Sale | 2,801 | $309.95 | $868,156.23 | filing |
| 2026-06-04 | KRYS | Krystal Biotech, Inc. | Sale | 2,039 | $310.94 | $634,000.54 | filing |
| 2026-06-04 | KRYS | Krystal Biotech, Inc. | Sale | 1,348 | $307.09 | $413,963.79 | filing |
| 2026-06-04 | KRYS | Krystal Biotech, Inc. | Sale | 593 | $302.25 | $179,234.72 | filing |
| 2026-06-04 | KRYS | Krystal Biotech, Inc. | Sale | 480 | $305.87 | $146,815.20 | filing |
| 2026-06-04 | KRYS | Krystal Biotech, Inc. | Sale | 400 | $304.89 | $121,957.56 | filing |
| 2026-06-04 | KRYS | Krystal Biotech, Inc. | Sale | 320 | $300.75 | $96,240.00 | filing |
| 2026-06-04 | KRYS | Krystal Biotech, Inc. | Sale | 247 | $303.17 | $74,883.06 | filing |
| 2026-06-04 | KRYS | Krystal Biotech, Inc. | Sale | 240 | $311.65 | $74,796.00 | filing |
| 2026-03-04 | KRYS | Krystal Biotech, Inc. | Sale | 6,000 | $265.16 | $1.6M | filing |
| 2026-03-04 | KRYS | Krystal Biotech, Inc. | Sale | 4,852 | $264.64 | $1.3M | filing |
| 2026-03-04 | KRYS | Krystal Biotech, Inc. | Sale | 3,667 | $260.37 | $954,762.49 | filing |
| 2026-03-04 | KRYS | Krystal Biotech, Inc. | Sale | 2,931 | $261.41 | $766,198.28 | filing |
| 2026-03-04 | KRYS | Krystal Biotech, Inc. | Sale | 2,248 | $263.58 | $592,534.81 | filing |
| 2026-03-04 | KRYS | Krystal Biotech, Inc. | Sale | 1,938 | $262.35 | $508,430.23 | filing |
| 2026-03-04 | KRYS | Krystal Biotech, Inc. | Sale | 1,700 | $266.42 | $452,918.08 | filing |
| 2026-03-04 | KRYS | Krystal Biotech, Inc. | Sale | 668 | $259.61 | $173,419.15 | filing |
| 2026-03-04 | KRYS | Krystal Biotech, Inc. | Sale | 589 | $258.54 | $152,280.30 | filing |
| 2026-03-04 | KRYS | Krystal Biotech, Inc. | Sale | 407 | $257.32 | $104,728.67 | filing |
| 2026-02-27 | KRYS | Krystal Biotech, Inc. | Tax withholding | 11,942 | $275.64 | $3.3M | filing |
| 2026-02-27 | KRYS | Krystal Biotech, Inc. | Tax withholding | 10,236 | $275.64 | $2.8M | filing |
| 2026-02-27 | KRYS | Krystal Biotech, Inc. | Tax withholding | 3,981 | $275.64 | $1.1M | filing |
| 2026-02-27 | KRYS | Krystal Biotech, Inc. | Tax withholding | 2,605 | $275.64 | $718,042.20 | filing |
| 2026-02-27 | KRYS | Krystal Biotech, Inc. | Tax withholding | 1,820 | $275.64 | $501,664.80 | filing |
| 2026-02-27 | KRYS | Krystal Biotech, Inc. | Option exercise | 8,750 | $0.00 | $0.00 | filing |
| 2026-02-27 | KRYS | Krystal Biotech, Inc. | Option exercise | 26,250 | $0.00 | $0.00 | filing |
| 2026-02-27 | KRYS | Krystal Biotech, Inc. | Option exercise | 4,000 | $0.00 | $0.00 | filing |
| 2026-02-27 | KRYS | Krystal Biotech, Inc. | Option exercise | 5,725 | $0.00 | $0.00 | filing |
| 2026-02-27 | KRYS | Krystal Biotech, Inc. | Option exercise | 22,500 | $0.00 | $0.00 | filing |
| 2025-12-05 | KRYS | Krystal Biotech, Inc. | Gift | 5,000 | $0.00 | $0.00 | filing |
| 2025-12-04 | KRYS | Krystal Biotech, Inc. | Sale | 10,505 | $221.78 | $2.3M | filing |
| 2025-12-04 | KRYS | Krystal Biotech, Inc. | Sale | 10,461 | $221.82 | $2.3M | filing |
| 2025-12-04 | KRYS | Krystal Biotech, Inc. | Sale | 5,693 | $219.53 | $1.2M | filing |
| 2025-12-04 | KRYS | Krystal Biotech, Inc. | Sale | 5,419 | $219.68 | $1.2M | filing |
| 2025-12-04 | KRYS | Krystal Biotech, Inc. | Sale | 3,593 | $218.83 | $786,244.69 | filing |
| 2025-12-04 | KRYS | Krystal Biotech, Inc. | Sale | 2,627 | $220.52 | $579,300.52 | filing |
| 2025-12-04 | KRYS | Krystal Biotech, Inc. | Sale | 2,625 | $220.34 | $578,394.60 | filing |
| 2025-12-04 | KRYS | Krystal Biotech, Inc. | Sale | 2,577 | $218.72 | $563,637.83 | filing |
| 2025-12-04 | KRYS | Krystal Biotech, Inc. | Sale | 1,600 | $217.04 | $347,271.68 | filing |
| 2025-12-04 | KRYS | Krystal Biotech, Inc. | Sale | 1,400 | $216.97 | $303,753.52 | filing |
| 2025-12-04 | KRYS | Krystal Biotech, Inc. | Sale | 956 | $214.28 | $204,851.39 | filing |
| 2025-12-04 | KRYS | Krystal Biotech, Inc. | Sale | 700 | $222.20 | $155,539.02 | filing |
| 2025-12-04 | KRYS | Krystal Biotech, Inc. | Sale | 700 | $214.25 | $149,975.21 | filing |
| 2025-12-04 | KRYS | Krystal Biotech, Inc. | Sale | 600 | $215.49 | $129,295.98 | filing |
| 2025-12-04 | KRYS | Krystal Biotech, Inc. | Sale | 344 | $215.48 | $74,125.60 | filing |
| 2025-12-04 | KRYS | Krystal Biotech, Inc. | Sale | 200 | $222.38 | $44,475.00 | filing |
| 2025-07-16 | KRYS | Krystal Biotech, Inc. | Sale | 1,529 | $150.00 | $229,350.00 | filing |
| 2025-07-16 | KRYS | Krystal Biotech, Inc. | Sale | 1,389 | $150.00 | $208,350.00 | filing |
| 2025-07-15 | KRYS | Krystal Biotech, Inc. | Sale | 2,236 | $150.68 | $336,929.20 | filing |
| 2025-07-15 | KRYS | Krystal Biotech, Inc. | Sale | 2,184 | $150.68 | $329,088.83 | filing |
| 2025-07-15 | KRYS | Krystal Biotech, Inc. | Sale | 900 | $151.79 | $136,611.00 | filing |
| 2025-07-15 | KRYS | Krystal Biotech, Inc. | Sale | 800 | $151.79 | $121,432.00 | filing |
| 2025-07-14 | KRYS | Krystal Biotech, Inc. | Sale | 13,400 | $150.30 | $2.0M | filing |
| 2025-07-14 | KRYS | Krystal Biotech, Inc. | Sale | 13,335 | $150.29 | $2.0M | filing |
| 2025-07-14 | KRYS | Krystal Biotech, Inc. | Sale | 100 | $151.00 | $15,100.00 | filing |
| 2025-07-10 | KRYS | Krystal Biotech, Inc. | Sale | 6,627 | $150.22 | $995,497.34 | filing |
| 2025-07-10 | KRYS | Krystal Biotech, Inc. | Sale | 6,500 | $150.23 | $976,463.80 | filing |
| 2025-07-10 | KRYS | Krystal Biotech, Inc. | Sale | 300 | $151.39 | $45,416.01 | filing |
| 2025-07-10 | KRYS | Krystal Biotech, Inc. | Sale | 300 | $151.39 | $45,416.01 | filing |
| 2025-07-09 | KRYS | Krystal Biotech, Inc. | Sale | 200 | $150.14 | $30,027.80 | filing |
| 2025-07-09 | KRYS | Krystal Biotech, Inc. | Sale | 200 | $150.07 | $30,014.00 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.